홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

p-Toluenesulfonic acid → 3-(2-butyl-5-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione

HRID 1409610
노트
인쇄 미리보기

반응식

HRID 1409610 반응식
[NH2:1][C:2]1[CH:18]=[CH:17][CH:16]=[C:15]([CH3:19])[C:3]=1[C:4]([NH:6][CH:7]1[CH2:12][CH2:11][C:10](=[O:13])[NH:9][C:8]1=[O:14])=[O:5].[C:20]1(C)[CH:25]=[CH:24]C(S(O)(=O)=O)=[CH:22][CH:21]=1>CN(C=O)C>[CH2:21]([C:22]1[N:6]([CH:7]2[CH2:12][CH2:11][C:10](=[O:13])[NH:9][C:8]2=[O:14])[C:4](=[O:5])[C:3]2[C:2](=[CH:18][CH:17]=[CH:16][C:15]=2[CH3:19])[N:1]=1)[CH2:20][CH2:25][CH3:24]
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 6101p-Toluenesulfonic acidHCID 659566542-amino-N-(2,6-dioxopiperidin-3-yl)-6-methylbenzamide

생성물 1

HCID 249675963-(2-butyl-5-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione수율 30.1%

시약·촉매·용매 1

HCID 6228Dimethylformamide용매

실험 절차

A solution of 2-amino-N-(2,6-dioxo-piperidin-3-yl)-6-methyl-benzamide (0.65 g, 2.5 mmol) and trimethyl orthopentionate (0.66 mL, 3.8 mmol) and p-toluenesulfonic acid (140 mg) in DMF (7 mL) was heated at 150° C. in a microwave oven for 20 minutes. The mixture was extracted with ethyl acetate (50 mL) and water (50 mL). The aqueous layer was extracted with ethyl acetate (50 mL). The combined organic layers was washed with water (50 mL), HCl (1N, 50 mL) and brine (50 mL). The solvent was removed in vacuo to give an oil, which was purified with column chromatography (Silica Gel, methanol/methylene chloride 0% gradient to 5% 15 min), and followed by reversed layer column chromatography (C-18, acetonitrile/water 0% gradient to 100% 15 min) to give 3-(2-butyl-5-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione as a white solid (80 mg, 10% yield): HPLC: Waters Symmetry C18, 5 μm, 3.9×150 mm, 1 mL/min, 240 nm, 10/90 grad 90/10 in 5 min CH3CN/0.1% H3PO4, 6.59 min (95.4%); mp: 190-192° C.; 1H NMR (DMSO-d6) δ 0.95 (t, J=8 Hz, 3H, CH3), 1.40-1.49 (m, 2H, CH2), 1.67-1.75 (m, 2H, CH2), 2.05-2.09 (m, 1H, CHH), 2.51-2.67 (m, 3H, CH2, CHH), 2.69 (s, 3H, CH3), 2.81-2.90 (m, 3H, CH2, CHH), 5.20 (dd, J=5, 11 Hz, 1H, NCH), 7.25 (d, J=7 Hz, 1H, Ar), 7.44 (d, J=8 Hz, 1H, Ar), 7.64 (t, J=8 Hz, 1H, Ar), 10.98 (s, 1H, NH); 13C NMR (DMSO-d6) δ 13.80, 21.11, 21.72, 22.48, 28.60, 30.50, 34.42, 55.41, 118.63, 124.98, 128.83, 133.70, 139.81, 148.25, 156.95, 161.17, 169.75, 172.65; LCMS: MH=328; Anal Calcd for C18H21N3O3: C, 66.04; H, 6.47; N, 12.84. Found: C, 65.87; H, 6.61; N, 12.89.

후처리

  1. extractionThe mixture was extracted with ethyl acetate (50 mL) and water (50 mL)
  2. extractionThe aqueous layer was extracted with ethyl acetate (50 mL)
  3. washThe combined organic layers was washed with water (50 mL), HCl (1N, 50 mL) and brine (50 mL)
  4. customThe solvent was removed in vacuo
  5. customto give an oil, which
  6. customwas purified with column chromatography (Silica Gel, methanol/methylene chloride 0% gradient to 5% 15 min)
  7. customfollowed by reversed layer column chromatography (C-18, acetonitrile/water 0% gradient to 100% 15 min)

출처 및 근거

ORD 기록
ord-070f4ad9e89d4c20ba1693309bb6746b
출처 데이터셋
uspto-grants-2014_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08921385B2

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트